- Transcatheter Arterial Chemoembolization Plus ¹³¹I-Labelled Metuximab versus Transcatheter Arterial Chemoembolization Alone in Intermediate/Advanced Stage Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
-
Zhu ZX, Liao MH, Wang XX, Huang JW
- KMID: 2466285
- Korean J Radiol.
- 2016 Dec;17(6):882-892.
- doi: 10.3348/kjr.2016.17.6.882
OBJECTIVE: The aim of the study was to compare transcatheter arterial chemoembolization (TACE) plus ¹³¹I-labelled metuximab with TACE alone for hepatocellular carcinoma (HCC). MATERIALS AND METHODS: A comprehensive search was conducted... -
- CITED
-
- Close
- SHARE
-
- Close
- Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma
-
Song MJ, Bae SH, Lee JS, Lee SW, Song DS, You CR, Choi JY, Yoon SK
- KMID: 2373799
- Korean J Intern Med.
- 2016 Mar;31(2):242-252.
- doi: 10.3904/kjim.2015.112
BACKGROUND/AIMS: We compared the recurrence of hepatocellular carcinoma (HCC) and the survival of patients who received radiofrequency ablation (RFA) after transarterial chemoembolization (TACE) with patients treated with TACE or RFA... -
- CITED
-
- Close
- SHARE
-
- Close
- CT Findings of Completely Regressed Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombosis after Transcatheter Arterial Chemoembolization
-
Yoon JH, Kim HC, Chung JW, Yoon JH, Jae HJ, Park JH
- KMID: 1787016
- Korean J Radiol.
- 2010 Feb;11(1):69-74.
- doi: 10.3348/kjr.2010.11.1.69
OBJECTIVE: The objective of this study was to determine the sequential CT findings of controlled hepatocellular carcinoma (HCC) with main portal vein (MPV) thrombosis with the use of transcatheter arterial... -
- CITED
-
- Close
- SHARE
-
- Close
- Use of 18F-FDG PET to predict tumor progression and survival in patients with intermediate hepatocellular carcinoma treated by transarterial chemoembolization
-
Kim MJ, Kim YS, Cho YH, Jang HY, Song JY, Lee SH, Jeong SW, Kim SG, Jang JY, Kim HS, Kim BS, Lee WH, Park JM, Lee JM, Lee MH, Choi DL
- KMID: 2160703
- Korean J Intern Med.
- 2015 May;30(3):308-315.
- doi: 10.3904/kjim.2015.30.3.308
BACKGROUND/AIMS: 18F-Fluorodeoxyglucose positron-emission tomography (18F-FDG PET) has been used to assess the biological behavior of hepatocellular carcinoma (HCC). In this study, we investigated the usefulness of 18F-FDG PET for predicting... -
- CITED
-
- Close
- SHARE
-
- Close
